Ae Wealth Management LLC Vaxart, Inc. Transaction History

Ae Wealth Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.57 - $0.85 $30 - $45	53 Added 0.09%	62,166 $35,000
Q3 2023 Oct 11, 2023	BUY	$0.69 - $0.85 $27,591 - $33,988	39,987 Added 180.72%	62,113 $46,000
Q2 2023 Jul 10, 2023	BUY	$0.6 - $1.41 $18 - $42	30 Added 0.14%	22,126 $16,000
Q1 2023 Apr 14, 2023	BUY	$0.71 - $1.25 $102 - $181	145 Added 0.66%	22,096 $16,000
Q4 2022 Jan 31, 2023	SELL	$0.75 - $2.24 $98 - $293	-131 Reduced 0.59%	21,951 $21,000
Q3 2022 Oct 25, 2022	BUY	$2.09 - $4.5 $491 - $1,057	235 Added 1.08%	22,082 $48,000
Q2 2022 Aug 03, 2022	BUY	$2.7 - $5.28 $15,697 - $30,697	5,814 Added 36.26%	21,847 $76,000
Q1 2022 Apr 18, 2022	SELL	$4.29 - $6.64 $729 - $1,128	-170 Reduced 1.05%	16,033 $81,000
Q4 2021 Jan 20, 2022	BUY	$5.77 - $7.96 $29,300 - $40,420	5,078 Added 45.64%	16,203 $102,000
Q3 2021 Nov 01, 2021	BUY	$6.67 - $9.8 $74,203 - $109,025	11,125 New	11,125 $88,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.